The School of Molecular & Cellular Biology and Department of Biochemistry are pleased to welcome Chu-Young Kim as a professor of biochemistry. We recently spoke with him about his research and teaching...

Congratulations to Professor Catherine Christian-Hinman, who was selected to receive the 2023 University of Virginia School of Medicine Distinguished Achievement Award in Biomedical Sciences. The award recognizes exceptional research and professional accomplishments, outstanding discovery and...

The School of Molecular & Cellular Biology and Department of Cell & Developmental Biology are pleased to welcome Boxuan Zhao as an assistant professor of cell and developmental biology. He will join us in...

Two faculty members in the School of Molecular & Cellular Biology have been selected as Emerging Research Leaders by the University of Illinois Interdisciplinary Health Sciences Institute. 

New research from University of Illinois biochemistry professor Raven Huang reveals that lethal ribosomal damage in bacteria can be reversed by a pair of bacterial enzymes named PrfH and RtcB. The finding raises the question of whether similar ribosomal damage can also be repaired in humans because...

The Cancer Center at Illinois is proud to announce the selection of nine interdisciplinary cancer research projects, involving multiple MCB faculty members, designed by University of Illinois Urbana-Champaign faculty to be funded by Cancer Center at Illinois (CCIL) developmental grant awards.

Castro joined the Department of Biochemistry in 2018 as a graduate student when he joined the Sweedler group to learn more about mass spectrometry. He works on developing new mass spectrometry approaches to measure individual cells and their chemical contents in a high-throughput fashion.

Breast cancer is categorized into three major subtypes: hormone receptor-positive, HER2-positive, and triple-negative. Although there are targeted therapeutic approaches for the first two, there are limited options for triple negative-breast cancer patients. In a new study, researchers have...

Stephen G. Sligar has spent the last 40 years at the University of Illinois Urbana-Champaign applying his expertise in membrane proteins and his nanodisc technology to better understand biological pathways and address diseases including cancer.

The Young Innovator program is designed to help trainees become innovative leaders in their fields. The students attended classes for ten weeks over the summer and, at the end of the program, participated in an idea competition, showcasing the projects.